Cargando…

High Antitumor Activity of the Dual Topoisomerase Inhibitor P8-D6 in Breast Cancer

SIMPLE SUMMARY: Despite significant advancement in therapeutic strategies, breast cancers remain the most prevalent type of cancer in terms of incidence and mortality worldwide. Therefore, new alternative therapies have become an urgent clinical need. The present study shows a significantly enhanced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Flörkemeier, Inken, Steinhauer, Tamara N., Hedemann, Nina, Weimer, Jörg Paul, Rogmans, Christoph, van Mackelenbergh, Marion T., Maass, Nicolai, Clement, Bernd, Bauerschlag, Dirk O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750241/ https://www.ncbi.nlm.nih.gov/pubmed/35008166 http://dx.doi.org/10.3390/cancers14010002

Ejemplares similares

Combined PARP and Dual Topoisomerase Inhibition Potentiates Genome Instability and Cell Death in Ovarian Cancer
por: Flörkemeier, Inken, et al.
Publicado: (2022)

Newly developed dual topoisomerase inhibitor P8-D6 is highly active in ovarian cancer
por: Flörkemeier, Inken, et al.
Publicado: (2021)

ADAM17—A Potential Blood-Based Biomarker for Detection of Early-Stage Ovarian Cancer
por: Rogmans, Christoph, et al.
Publicado: (2021)

Nectin-4 as Blood-Based Biomarker Enables Detection of Early Ovarian Cancer Stages
por: Rogmans, Christoph, et al.
Publicado: (2022)

ADAM17 Inhibition Increases the Impact of Cisplatin Treatment in Ovarian Cancer Spheroids
por: Hedemann, Nina, et al.
Publicado: (2021)

ADAM17 inhibition enhances platinum efficiency in ovarian cancer
por: Hedemann, Nina, et al.
Publicado: (2018)

Chemotherapy‐induced release of ADAM17 bearing EV as a potential resistance mechanism in ovarian cancer
por: Hugendieck, Gerrit, et al.
Publicado: (2023)

The Aza-Analogous Benzo[c]phenanthridine P8-D6 Acts as a Dual Topoisomerase I and II Poison, thus Exhibiting Potent Genotoxic Properties
por: Aichinger, Georg, et al.
Publicado: (2020)

Fluorescence in situ hybridization test for detection of endometrial carcinoma cells by non‐invasive vaginal swab
por: Weimer, Jörg, et al.
Publicado: (2023)

Bispecific antibodies enhance tumor‐infiltrating T cell cytotoxicity against autologous HER‐2‐expressing high‐grade ovarian tumors
por: Oberg, Hans‐Heinrich, et al.
Publicado: (2019)

Endometrial Carcinoma Presenting as Vasculitic Sensorimotor Polyneuropathy
por: Vasku, Marketa, et al.
Publicado: (2011)

Challenges in the Diagnosis and Individualized Treatment of Cervical Cancer
por: Schubert, Melanie, et al.
Publicado: (2023)

Fertility Preservation in Female Patients with Breast Cancer – a Current Overview
por: Guenther, Veronika, et al.
Publicado: (2017)

In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cells
por: Weigel, Marion T, et al.
Publicado: (2010)

Tetraspanin 8 Subfamily Members Regulate Substrate-Specificity of a Disintegrin and Metalloprotease 17
por: Müller, Miryam, et al.
Publicado: (2022)

Evaluation of Laparoscopy Virtual Reality Training on the Improvement of Trainees’ Surgical Skills
por: Elessawy, Mohamed, et al.
Publicado: (2021)

Evodiamine-inspired dual inhibitors of histone deacetylase 1 (HDAC1) and topoisomerase 2 (TOP2) with potent antitumor activity
por: Huang, Yahui, et al.
Publicado: (2020)

Dual Inhibitors Against Topoisomerases and Histone Deacetylases
por: Seo, Young Ho
Publicado: (2015)

Inhibition of Topoisomerase II by a Novel Antitumor Cyclic Depsipeptide, BE‐22179
por: Yoshinari, Tomoko, et al.
Publicado: (1994)

Challenges and Controversies in the Surgical Treatment of Cervical Cancer: Open Radical Hysterectomy versus Minimally Invasive Radical Hysterectomy
por: Röseler, Jona, et al.
Publicado: (2021)

MSN8C: A Promising Candidate for Antitumor Applications as a Novel Catalytic Inhibitor of Topoisomerase II
por: Ou, Jie-Bin, et al.
Publicado: (2023)

The antitumor activity of CYB-L10, a human topoisomerase IB catalytic inhibitor
por: Yu, Qian, et al.
Publicado: (2019)

In Vitro and In Silico Characterization of an Antimalarial Compound with Antitumor Activity Targeting Human DNA Topoisomerase IB
por: Soren, Bini Chhetri, et al.
Publicado: (2021)

Identification of Novel 4′-O-Demethyl-epipodophyllotoxin Derivatives as Antitumor Agents Targeting Topoisomerase II
por: Xi, Wenli, et al.
Publicado: (2022)

Metastases-directed Radiotherapy in Addition to Standard Systemic Therapy in Patients with Oligometastatic Breast Cancer: Study protocol for a randomized controlled multi-national and multi-center clinical trial (OLIGOMA)
por: Krug, David, et al.
Publicado: (2021)

Dual Role of Topoisomerase II in Centromere Resolution and Aurora B Activity
por: Coelho, Paula A, et al.
Publicado: (2008)

Topoisomerase-I PS506 as a Dual Function Cancer Biomarker
por: Zhao, Ming, et al.
Publicado: (2015)

Hybrid topoisomerase I and HDAC inhibitors as dual action anticancer agents
por: Cincinelli, Raffaella, et al.
Publicado: (2018)

Dual Targeting Topoisomerase/G-Quadruplex Agents in Cancer Therapy—An Overview
por: Salerno, Silvia, et al.
Publicado: (2022)

Mucinous Cystic Neoplasm of Pancreas in a Pregnant Woman Presenting with Severe Anemia and Gastric Bleeding: Case Report and Review of the Literature
por: Farahmandi, Susan, et al.
Publicado: (2021)

Fatty acid synthase overexpression: target for therapy and reversal of chemoresistance in ovarian cancer
por: Bauerschlag, Dirk O, et al.
Publicado: (2015)

Antitumor Activity of a Novel Quinoline Derivative, TAS‐103, with Inhibitory Effects on Topoisomerases I and II
por: Utsugi, Teruhiro, et al.
Publicado: (1997)

In vitro Antitumor Activity of TAS‐103, a Novel Quinoline Derivative That Targets Topoisomerases I and II
por: Aoyagi, Yoshimi, et al.
Publicado: (1999)

Correction: SNiPER: a novel hypermethylation biomarker panel for liquid biopsy based early breast cancer detection
por: Mijnes, Jolein, et al.
Publicado: (2020)

SNiPER: a novel hypermethylation biomarker panel for liquid biopsy based early breast cancer detection
por: Mijnes, Jolein, et al.
Publicado: (2019)

Effects of camptothecin derivatives and topoisomerase dual inhibitors on Trypanosoma cruzi growth and ultrastructure
por: Lacombe, Otto Kischlat, et al.
Publicado: (2014)

Antibacterial activity of novel dual bacterial DNA type II topoisomerase inhibitors
por: D’Atanasio, Noemi, et al.
Publicado: (2020)

Topoisomerase IV can functionally replace all type 1A topoisomerases in Bacillus subtilis
por: Reuß, Daniel R, et al.
Publicado: (2019)

Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demand
por: Amoury, Manal, et al.
Publicado: (2016)

A New Antitumor Agent Amrubicin Induces Cell Growth Inhibition by Stabilizing Topoisomerase II‐DNA Complex
por: Hanada, Mitsuharu, et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_9mto6rkcrodimg414vbpdija2v